Offer - Urjas Oil for just ₹ 1 X
Relicalm Sf is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Schizophrenia, Mania, Parkinson's Disease. Relicalm Sf also has some secondary and off-label uses. These are listed below.
The optimal dosage of Relicalm Sf is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Relicalm Sf include Nausea or vomiting. Some other side effects of Relicalm Sf have been listed ahead. Such side effects of Relicalm Sf normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Relicalm Sf is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Relicalm Sf's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Heart Disease, High Blood Pressure, Depression must refrain from the use of Relicalm Sf since this can cause severe adverse effects. The section on Relicalm Sf contraindications lists all such conditions.
Drug interactions for Relicalm Sf have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Relicalm Sf is not safe while driving, and is is not addictive in nature.
Relicalm Sf is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Relicalm Sf safe for pregnant women?
Relicalm Sf can have harmful effects in pregnant women. If you experience any discomfort after using Relicalm Sf, then discontinue the use and take your doctor's advice.
Is the use of Relicalm Sf safe during breastfeeding?
Taking Relicalm Sf may lead to serious side effects if you are breastfeeding. Relicalm Sf should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Relicalm Sf on the Kidneys?
Information about safety of Relicalm Sf for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Relicalm Sf on the Liver?
There is no research available on the side effects of Relicalm Sf on the liver. Therefore, its impact is unknown.
What is the effect of Relicalm Sf on the Heart?
Relicalm Sf may have mild side effects on the heart. Most people will never see any effect on the heart.
Relicalm Sf should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Relicalm Sf unless your doctor advises you to do so -
Is this Relicalm Sf habit forming or addictive?
No, you will not get addicted to Relicalm Sf.
Interaction between Food and Relicalm Sf
Taking Relicalm Sf with food does not harm your health.
Interaction between Alcohol and Relicalm Sf
Taking alcohol with Relicalm Sf can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trihexyphenidyl Hydrochloride (trihexyphenidyl hydrochloride)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Artane (trihexyphenidyl hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 439-440